PF-Atlas › Clinical Trials › NCT00043316

Interferon Gamma-1b by Inhalation for the Treatment of Patients With Cystic Fibrosis

interferon gamma-1b · Phase 1

Registry ID
NCT00043316
Phase
Phase 1
Status
Completed
Drug / intervention
interferon gamma-1b
Sponsor
InterMune
Start
2001-02

About this trial

interferon gamma-1b is evaluated in NCT00043316, a Phase 1 idiopathic pulmonary fibrosis study sponsored by InterMune. Current status: Completed.

View NCT00043316 on ClinicalTrials.gov →

Explore related

All interferon gamma-1b trialsAll IPF trials

Related trials

interferon gamma-1b — NCT00043342Interferon gamma-1b — NCT00075998
Medical disclaimer. This page summarizes public trial data for NCT00043316 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.